Immuneering announces public offering, $25M private placement with Sanofi; shares up 55%
2025-09-24 16:28:39 ET
More on Immuneering
- Immuneering Corporation: Ripping On A Questionable Catalyst
- Immuneering signs supply deal with Lilly to test atebimetinib plus olomorasib
- Immuneering announces $25M private placement with premium pricing; shares up nearly 8%
- Seeking Alpha’s Quant Rating on Immuneering
- Historical earnings data for Immuneering
Read the full article on Seeking Alpha
For further details see:
Immuneering announces public offering, $25M private placement with Sanofi; shares up 55%NASDAQ: SN
SN Trading
-3.95% G/L:
$109.42 Last:
139,600 Volume:
$110.59 Open:



